INPP5D and diffuse large B-cell lymphoma: Intriguingly anti- TNF-α drugs (eternacept or infliximab) were able to reverse these effects leading to the reduction of miR-155 levels and the restoration of INPP5D expression in DLBCL cells in vitro, and to the subsequent inhibition of cell proliferation and tumour growth in vivo [67].